Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Champions Oncology Inc.

    NASDAQ: CSBR · Real-Time Price · USD
    6.36
    0.08 (1.27%)
    At close: May 16, 2025, 3:59 PM
    6.35
    -0.16%
    After-hours: May 16, 2025, 05:35 PM EDT
    1.27%
    Bid 5.81
    Market Cap 87.94M
    Revenue (ttm) 58.59M
    Net Income (ttm) 6.43M
    EPS (ttm) 0.45
    PE Ratio (ttm) 14.13
    Forward PE 29.41
    Analyst Strong Buy
    Ask 6.48
    Volume 11,775
    Avg. Volume (20D) 40,898
    Open 6.02
    Previous Close 6.28
    Day's Range 6.02 - 6.38
    52-Week Range 3.60 - 11.99
    Beta 0.51

    About CSBR

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol CSBR
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for CSBR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    5 months ago
    +12.09%
    Champions Oncology shares are trading higher after... Unlock content with Pro Subscription
    8 months ago
    +9.58%
    Champions Oncology shares are trading higher after the company reported better-than-expected Q1 financial results. Also, Craig-Hallum upgraded the stock from Hold to Buy and maintained its $6 price target.
    news image

    2 weeks ago · accessnewswire.com

    Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House

    HACKENSACK, NJ / ACCESS Newswire / April 28, 2025 / Champions Oncology (NASDAQ:CSBR), a leader in translational oncology research, has been granted a license to use radioactive materials in preclinica...

    news image

    2 months ago · seekingalpha.com

    Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Call Transcript

    Champions Oncology, Inc. (NASDAQ:CSBR ) Q3 2025 Earnings Conference Call March 11, 2025 4:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Conference Call Participants Maj Soueidan...

    news image

    2 months ago · accessnewswire.com

    Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million

    HACKENSACK, NJ / ACCESS Newswire / March 11, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, toda...

    news image

    2 months ago · accessnewswire.com

    Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025

    HACKENSACK, NJ / ACCESS Newswire / March 6, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will ...

    Add to Watchlist